Pharma and IT stocks were the predominant gainers on the bourses on Thursday morning, with Sun Pharma and Cipla among the top gainers along with IT... ...http://www.thehindubusinessline.com/markets/stock-markets/sun-pharma-leads-the-pack-on-bse-up-nearly-2/article5477578.ece
Shobha Shukla, Citizen News Service CNS To tackle any disease it is not merely only diagnosing correctly and offering quality treatment but... ...http://www.mangalorean.com/news.php?newstype=local&newsid=446237
Cipla is currently trading at Rs. 391.05, up by 3.25 points or 0.84% from its previous closing of Rs. 387.80 on the BSE. The scrip opened at Rs.... ...http://www.indian-commodity.com/equity/cipla-soars-on-getting-us-fda-approval-for-xopenex.aspx
Markets have extended gains with Sensex trading above 20,700 mark and Nifty inching towards 6,200. A bout of volatility was witnessed in early... ...http://www.business-standard.com/article/markets/market-edges-higher-capital-goods-surge-113121800188_1.html
Pharma majors Cipla has received US Food and Drug Administration (US FDA) approval for the generic version of the drug called Xopenex, which is... ...http://www.indian-commodity.com/corporate/cipla-gets-us-fda-approval-for-xopenex.aspx
hiii. ..I am leading a education hub...
Discover the difference with...